Table 1:

Characteristics of cases and controls

CharacteristicCases, n = 1292Controls, n = 12 651p value*
Age, median (IQR)62 (54–72)62 (54–72)0.3
Disease state,no. (%)
Cancer227 (17.6)2183 (17.3)0.8
Chronic obstructive pulmonary disease121 (9.4)1264 (10.0)0.5
Congestive heart failure198 (15.3)1156 (9.1)< 0.001
Diabetes mellitus461 (35.7)3068 (24.3)< 0.001
HIV8 (0.6)34 (0.3)0.053
Hypertension567 (43.9)4714 (37.3)< 0.001
Medications,no. (%)
Loop diuretics115 (8.9)654 (5.2)< 0.001
Nonsteroidal anti-inflammatory drugs15 (1.2)167 (1.3)0.8
Renin–angiotensin-system blockers228 (17.7)1770 (14.0)< 0.001
Health care use,§median (IQR)
Billing codes, no.29 (11–62)39 (18–69)0.005
Drugs, no.16 (4–31)11 (3–22)< 0.001
Physician visits, no.4 (2–8)4 (2–7)0.2
Fluoroquinolone indications,§no. (%)
Joint or bone infection17 (1.3)143 (1.1)0.8
Skin infection430 (33.3)4093 (32.4)0.5
Tract infection
 Genitourinary179 (13.9)1287 (10.2)< 0.001
 Respiratory490 (37.9)5206 (41.2)0.03
 Gastrointestinal309 (23.9)3108 (24.6)0.6
  • Note: IQR = interquartile range.

  • * Calculated using χ2 test for categorical characteristics and Student t test for continuous characteristics.

  • In the year before admission to hospital to maximize sensitivity.

  • Current medication use at the time of hospital admission was used to best assess use at the index date.

  • § In the 6 months before admission to hospital to reflect covariates during exposure ascertainment.